Kinase activity of mutant LRRK2 mediates neuronal toxicity

被引：507

作者：

Smith, Wanli W.

Pei, Zhong

Jiang, Haibing

Dawson, Valina L.

Dawson, Ted M.

Ross, Christopher A.

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA

[3] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA

[4] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21287 USA

[5] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA

[6] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA

来源：

NATURE NEUROSCIENCE | 2006年 / 9卷 / 10期

关键词：

D O I：

10.1038/nn1776

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal- dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity. These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.

引用

页码：1231 / 1233

页数：3

共 50 条

[1] Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W Smith
Zhong Pei
Haibing Jiang
Valina L Dawson
Ted M Dawson
Christopher A Ross
Nature Neuroscience, 2006, 9 : 1231 - 1233
[2] Mutant LRRK2 Toxicity in Neurons Depends on LRRK2 Levels and Synuclein But Not Kinase Activity or Inclusion Bodies
Skibinski, Gaia
Nakamura, Ken
Cookson, Mark R.
Finkbeiner, Steven
JOURNAL OF NEUROSCIENCE, 2014, 34 (02): : 418 - 433
[3] Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
Smith, WW
Pei, Z
Jiang, HB
Moore, DJ
Liang, YD
West, AB
Dawson, VL
Dawson, TM
Ross, CA
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18676 - 18681
[4] Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, Elisa
Jain, Shushant
Kingsbury, Ann
Bandopadhyay, Rina
Lewis, Patrick
Kaganovich, Alice
van der Brug, Marcel P.
Beilina, Alexandra
Blackinton, Jeff
Thomas, Kelly Jean
Ahmad, Rill
Miller, David W.
Kesavapany, Sashi
Singleton, Andrew
Lees, Andrew
Harvey, Robert J.
Harvey, Kirsten
Cookson, Mark R.
NEUROBIOLOGY OF DISEASE, 2006, 23 (02) : 329 - 341
[5] Characterization of LRRK2 kinase activity
Ryder, J. W.
Anderson, B. D.
Huss, K. A.
Wang, X.
Qian, Y. -W.
Campbell, R. M.
Merchant, K. M.
MOVEMENT DISORDERS, 2008, 23 (01) : S29 - S30
[6] LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
Taymans, Jean-Marc
Vancraenenbroeck, Renee
Ollikainen, Petri
Beilina, Alexandra
Lobbestael, Evy
De Maeyer, Marc
Baekelandt, Veerle
Cookson, Mark R.
PLOS ONE, 2011, 6 (08):
[7] Neuronal death signaling pathways triggered by mutant LRRK2
Rideout, Hardy J.
BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 : 123 - 129
[8] LRRK2 Kinase Activity is Dependent on Dimerization
Sen, Saurabh
West, Andrew
FASEB JOURNAL, 2010, 24
[9] Assaying the Kinase Activity of LRRK2 in vitro
Lewis, Patrick A.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (59):
[10] Impact of adenosine signaling on mutant LRRK2 induced neuronal injury
Steer, Erin
Chu, Charleen
FASEB JOURNAL, 2012, 26

← 1 2 3 4 5 →